Chicago Capital Management LLC cut its position in shares of Fortress Investment Group LLC (NYSE:FIG) by 0.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,699,263 shares of the asset manager’s stock after
Trust Asset Management LLC continued to hold its stake in CenturyLink, Inc. (NYSE:CTL) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,431 shares of the technology company’s stock at the end of the
Constellation Brands Inc (NYSE:STZ) has been assigned an average rating of “Buy” from the twenty analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued
La Jolla Pharmaceutical Company (NASDAQ:LJPC) has earned a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to
Lowe Wealth Advisors LLC held its stake in Newmont Mining Corporation (NYSE:NEM) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,220 shares of the basic materials company’s stock at the end of the second
Global Payments Inc. (NYSE:GPN) Director William I. Jacobs sold 600 shares of the business’s stock in a transaction dated Thursday, July 13th. The stock was sold at an average price of $90.52, for a total transaction of $54,312.00. Following the sale, the director now directly
Bridge Bancorp, Inc. (NASDAQ:BDGE) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, July 12th. BDGE has been the subject of a number of other reports. Zacks
Texas Capital Bancshares, Inc. (NASDAQ:TCBI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, July 11th. The brokerage presently has a $87.00 price target on the bank’s stock. Zacks
Zacks Investment Research upgraded shares of Clovis Oncology, Inc. (NASDAQ:CLVS) from a hold rating to a buy rating in a research report sent to investors on Wednesday, July 12th. Zacks Investment Research currently has $105.00 target price on the biopharmaceutical company’s stock. According to Zacks,
Baltimore Washington Financial Advisors Inc. boosted its position in Intercontinental Exchange Inc. (NYSE:ICE) by 1.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,152 shares of the financial services provider’s stock